Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for MHTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2024 0.004M
March 31, 2024 0.026M
December 31, 2023 -0.008M
September 30, 2023 0.084M
June 30, 2023 0.026M
March 31, 2023 0.00
December 31, 2022 0.004M
September 30, 2022 0.00
June 30, 2022 0.328M
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.003M
June 30, 2021 0.30M
March 31, 2021 -0.003M
December 31, 2020 0.00
September 30, 2020 0.10M
June 30, 2020 0.30M
March 31, 2020 0.08M
December 31, 2019 0.04M
September 30, 2019 0.002M
June 30, 2019 0.30M
March 31, 2019 -0.002M
December 31, 2018 0.00
September 30, 2018 0.50M
June 30, 2018 0.00
Date Value
March 31, 2018 0.00
December 31, 2017 -0.968M
September 30, 2017 -0.008M
June 30, 2017 0.991M
March 31, 2017 -0.023M
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 -0.013M
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 -0.013M
June 30, 2015 -0.165M
March 31, 2015 -0.077M
December 31, 2014 -0.017M
September 30, 2014 -0.017M
June 30, 2014 -0.002M
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 -0.179M
June 30, 2013 0.00
March 31, 2013 0.00
December 31, 2012 0.00
September 30, 2012 0.00
June 30, 2012 0.00
March 31, 2012 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 0.00
Exicure, Inc. 0.00
Century Therapeutics, Inc. 17.77M
Absci Corp. 24.07M
Celularity, Inc. 0.00